- Research article
- Open Access
A novel type of N-acetylglutamate synthase is involved in the first step of arginine biosynthesis in Corynebacterium glutamicum
© Petri et al.; licensee BioMed Central Ltd. 2013
- Received: 28 March 2013
- Accepted: 15 October 2013
- Published: 18 October 2013
Arginine biosynthesis in Corynebacterium glutamicum consists of eight enzymatic steps, starting with acetylation of glutamate, catalysed by N-acetylglutamate synthase (NAGS). There are different kinds of known NAGSs, for example, “classical” ArgA, bifunctional ArgJ, ArgO, and S-NAGS. However, since C. glutamicum possesses a monofunctional ArgJ, which catalyses only the fifth step of the arginine biosynthesis pathway, glutamate must be acetylated by an as of yet unknown NAGS gene.
Arginine biosynthesis was investigated by metabolome profiling using defined gene deletion mutants that were expected to accumulate corresponding intracellular metabolites. HPLC-ESI-qTOF analyses gave detailed insights into arginine metabolism by detecting six out of seven intermediates of arginine biosynthesis. Accumulation of N-acetylglutamate in all mutants was a further confirmation of the unknown NAGS activity. To elucidate the identity of this gene, a genomic library of C. glutamicum was created and used to complement an Escherichia coli ΔargA mutant. The plasmid identified, which allowed functional complementation, contained part of gene cg3035, which contains an acetyltransferase domain in its amino acid sequence. Deletion of cg3035 in the C. glutamicum genome led to a partial auxotrophy for arginine. Heterologous overexpression of the entire cg3035 gene verified its ability to complement the E. coli ΔargA mutant in vivo and homologous overexpression led to a significantly higher intracellular N-acetylglutamate pool. Enzyme assays confirmed the N-acetylglutamate synthase activity of Cg3035 in vitro. However, the amino acid sequence of Cg3035 revealed no similarities to members of known NAGS gene families.
The N-acetylglutamate synthase Cg3035 is able to catalyse the first step of arginine biosynthesis in C. glutamicum. It represents a novel class of NAGS genes apparently present only in bacteria of the suborder Corynebacterineae, comprising amongst others the genera Corynebacterium, Mycobacterium, and Nocardia. Therefore, the name C-NAGS (Corynebacterineae-type NAGS) is proposed for this new family.
- Corynebacterium glutamicum
- N-acetylglutamate synthase
- Arginine biosynthesis
Enzymes catalysing the formation of N-acetylglutamate in prokaryotes exhibit a high degree of diversity. N-acetylglutamate synthase activity was first discovered in Escherichia coli. Here, the two-domain protein ArgA contains a carbamate kinase domain at its N-terminus that is homologous to the next enzyme in arginine biosynthesis, N-acetylglutamate kinase (NAGK, ArgB) . The N-acetylglutamate synthase domain, as well as an acetyl-CoA binding region, is located at the C-terminus of ArgA. This domain is related to the large family of GCN5-related acetyltransferases (GNAT) . ArgA from E. coli is strongly feedback-inhibited by l-arginine, leading to 50% inhibition at 0.02 mM . Coenzyme A and N-acetylglutamate also inhibit the activity of this enzyme: 2.5 mM CoA or 25 mM N-acetylglutamate both result in 50% inhibition of ArgA . In E. coli, removal of the acetyl group is catalysed by ArgE (N-acetylornithine deacetylase) during the fifth step of arginine biosynthesis, which results in a linear pathway .
For the acetylated intermediates, the majority of prokaryotes have a more efficient cyclic pathway in which ArgJ (ornithine acetyltransferase, OAT) catalyses the acetylation of glutamate . ArgJ operates as a bifunctional protein and uses both substrates, acetyl-CoA and N-acetylornithine, thus, this enzyme exhibits both NAGS and OAT activity . In this case, NAGS activity is essential for priming arginine biosynthesis, but it has only an anaplerotic function while most N-acetylglutamate is produced by ArgJ using l-glutamate and N-acetylornithine as substrates. The acetyl group is recycled via transacetylation of l-glutamate. Therefore the latter reaction is generally preferred, explaining the low abundance of NAGS enzymes in organisms exhibiting OAT .
Regulation of this metabolic pathway is generally achieved through feedback inhibition of the second enzyme in the pathway, N-acetylglutamate kinase (ArgB) by l-arginine  and/ or by feedback inhibition of ArgJ by l-ornithine .
In most bacteria, either a bifunctional ArgJ or ArgA is responsible for formation of N-acetylglutamate. However, there also exist some organisms such as Neisseria gonorrhoeae or Bacillus stearothermophilus exhibiting both a bifunctional OAT as well as a NAGS gene. There are also OATs which are unable to use acetyl-CoA as substrate and are, therefore, designated as ‘monofunctional’. An additional NAGS gene is needed in this case, however, in organisms such as Streptomyces coelicolor or Thermus thermophilus, both encoding a monofunctional ArgJ, no orthologue of ArgA can be identified by sequence similarity searches . In these organisms, the glutamate acetylation mechanism remains unclear, however, in 2005, Errey et al. discovered a novel ArgA protein in Mycobacterium tuberculosis, containing only a single domain and consisting of 174 amino acids . This “short NAGS” version (S-NAGS) is a putative GNAT-related enzyme and was later also found in other genera including Thermus and Streptomyces. The proteins of this family possess only 150 to 180 amino acids, similar to the length of the C-terminal acetyl-CoA domain of classical NAGS, however, are able to complement E. coli argA mutants .
In addition to single-domain S-NAGSs, another group of proteins exists in which a S-NAGS domain is fused with an N-argininosuccinase (ArgH) domain, the protein that catalyses the last step of the l-arginine biosynthesis pathway. The argH(A) genes were found mainly in marine bacteria of the Alteromonas-Vibrio group [14, 15]. It is speculated that these S-NAGSs always require a complex formation with a protein partner providing an efficient glutamate binding site .
Corynebacterium glutamicum is a natural producer of l-glutamate, a precursor of l-arginine and, accordingly, its arginine biosynthesis has been the subject of intense research. The earliest studies of this organism were performed in 1958 by Udaka and Kinoshita, who analysed the metabolic pathway of l-ornithine, an intermediate of the arginine pathway. The authors recognised that acetylated compounds form a cycle of reactions, in which the acetyl group is recycled by generation of N-acetylglutamate . Hence, it was concluded that C. glutamicum exhibits an OAT activity catalysed by ArgJ. In 1996, Sakanyan et al. discovered the monofunctional action of ArgJ by revealing its ability to complement E. coli argE but not argA mutants. By performing enzyme inhibition tests, they detected no influence on OAT activity by l-arginine, however, a product inhibition was shown when 5 mM l-ornithine was added to the ArgJ enzyme .
Nevertheless, ArgJ lacks NAGS activity and so investigations to discover a glutamate acetylase responsible for the first step in arginine biosynthesis were performed. Recently, Hwang and Cho , who searched for C. glutamicum N-acetyltransferase genes complementing an auxotrophic ∆argJ mutant, claimed that Cg1722 (NCgl1469) demonstrates NAGS activity and that its overexpression leads to an increase in ornithine production. But shortly thereafter Kind et al. revealed that Cg1722 acetylates diaminopentane (cadavarine) instead of glutamate, so that the NAGS gene of C. glutamicum is still unknown.
In the work described here, we analysed arginine synthesis in C. glutamicum by individually mutating single genes known to be involved in this synthesis pathway and determining the patterns of accumulated metabolic intermediates. In a complementation approach, we identified a C. glutamicum gene able to complement an arginine-auxotrophic E. coli argA mutant. Enzyme activity tests as well as metabolic profiling demonstrated that this gene is the functional analogue of ArgA in C. glutamicum.
Arginine biosynthesis of C. glutamicum was an integral part of a number of previous studies which have elucidated detailed knowledge of the genetic and enzymatic organisation of this pathway , its regulation by the transcriptional regulator ArgR, as well as the feedback inhibition of ArgB by the end-product of the pathway, l-arginine . In order to complement the existing understanding of this pathway, we chose to characterise the metabolic intermediates of arginine metabolism using defined individual knock-out mutants of all known arginine biosynthesis genes located in the arginine operon .
Comparison of metabolite profiles of different arginine auxotrophic strains revealed that the intracellular intermediates N-acetylglutamate semialdehyde, ornithine and N-argininosuccinate were only accumulated in their corresponding mutant, namely in ΔargRD, ΔargRF, or ΔargRH, respectively. However, citrulline was detected in samples of strains ΔargRG, and ΔargRH. The latter finding could indicate a backlog from N-argininosuccinate to citrulline or, alternatively, a low conversion rate of argininosuccinate synthetase. N-Acetylornithine was also found in two of the mutants. A high pool size of this compound was observed in ∆argRJ and a lower pool size in ∆argRF, which again might imply a backlog. The accumulation of N-acetylornithine in ∆argRJ provides clear in vivo evidence for a NAGS activity in C. glutamicum, catalysed by at least one other enzyme than ArgJ. Former experiments performed by Sakanyan et al. in 1996 revealed that ArgJ of C. glutamicum only exhibited monofunctional enzyme activity in vitro and in vivo.
N-Acetylglutamate was the only metabolite intermediate detectable in the wildtype and in all mutants. As in the ∆argRJ mutant, the N-acetylglutamate pool was significantly reduced in the ∆argRD strain, most probably due to the lack of substrate for transacetylation by ArgJ. However, the relatively high N-acetylglutamate pool in the ∆argRC mutant is not directly explained by this.
Discovering a gene responsible for the first step of arginine biosynthesis
For identification of a gene encoding the missing N-acetylglutamate synthase in C. glutamicum ATCC 13032, an E. coli JM109 ∆argA mutant was constructed by using Red/ET recombination. After successful integration of the gene deletion cassette, the selection marker was removed by using FLP recombination. The constructed mutant was tested on M9 minimal medium and no growth was observed without l-arginine supplementation. Furthermore, arginine auxotrophy of this mutant was not complemented by ArgJ from C. glutamicum, as described in literature .
The genomic organisation of cg3035 revealed an operon structure together with cg3034, coding for def1, a putative peptide deformylase, since coding sequences of these two genes share an 11 bp long overlap. Moreover, this implies a co-regulation of both proteins by translational coupling. The gene product of cg3035 is 37.2 kDa in size and possesses an acetyltransf_1 (PF00583)-domain catalysing transfer of an acetyl group to its substrate . A coenzyme A binding pocket is located upstream of the acetyltransferase domain. Nevertheless, an experimental validation of Cg3035 protein function was necessary.
Validating the gene function of cg3035 by heterologous complementation, gene deletion, metabolome analyses, and enzyme assays
The complete open reading frame of cg3035 was amplified from C. glutamicum WT genome by PCR and cloned into pZ8-1 together with a consensus ribosome-binding site (RBS) of highly expressed genes . ArgA from E. coli was treated similarly to serve as positive control. The resulting plasmids (pZ8-1::argA, pZ8-1::cg3035) were transformed into E. coli ΔargA. As expected, argA from E. coli allowed growth of arginine-auxotrophic mutant on minimal medium plates without l-arginine supplementation. Growth on minimal medium was also restored by cg3035, showing a functional complementation.
To test whether cg3035 is involved in arginine biosynthesis in C. glutamicum, growth of the deletion mutant ∆cg3035 was analysed on solid minimal medium without l-arginine supplementation and compared to the C. glutamicum wildtype (Additional file 3). After 48 h at 30°C the mutant ∆cg3035 exhibits poor growth on unsupplemented MM1 plates in comparison to the C. glutamicum wildtype, indicating a bradytrophy of the mutant due to arginine limitation. Therefore, Cg3035 is required for full activity of arginine biosynthesis in C. glutamicum, but not essential.
Specific NAGS activities of C. glutamicum ATCC 13032 and C. glutamicum ∆ cg3035 carrying different plasmids
Specific NAGS activity
SD [mU mg-1protein]b
C. glutamicum ATCC 13032
C. glutamicum ATCC 13032
C. glutamicum ATCC 13032
C. glutamicum ATCC 13032
C. glutamicum ∆cg3035
C. glutamicum ∆cg3035
In addition, NAGS activities of overexpressed ArgA of E. coli and ArgJ of C. glutamicum were measured in the wildtype background. As expected, ArgJ exhibited no specific NAGS activity, explaining its inability to complement the E. coli ∆argA mutant. ArgA from E. coli was found to confer additional NAGS activity of approximately 18.6 mU mg-1 protein.
For a number of microorganisms, including E. coli[27, 28], Salmonella enterica serovar Typhimurium , Pseudomonas aeruginosa, and Saccharomyces cerevisiae, a strong feedback inhibition of NAGS activity by l-arginine was found. Therefore, inhibition studies of Cg3035 with l-arginine and also with the intermediate l-ornithine were performed. No changes in specific NAGS activity of the crude extract of C. glutamicum ATCC 13032 pZ8-1::cg3035 were detected when up to 50 mM l-ornithine or l-arginine was added to the reaction mixture (data not shown).
Cg3035 establishes a novel class of NAGS genes
To determine how related Cg3035 is to other known NAGS genes, comparisons between “classical” ArgA proteins, bifunctional ArgJ, S-NAGS and ArgO from Campylobacter jejuni were performed by sequence similarity-based searches with the Cg3035 protein sequence using the basic local alignment search tool (BLAST)  at the NCBI. Cg3035 did not show significant overall sequence similarities to members of other classes. Sequence similarity is restricted to the acetyltransferase catalytic domain, being distantly related to that of ArgA from E. coli (28% identity in 40 amino acids), ArgJ from Bacillus subtilis (29% identity in 41 amino acids) and the S-NAGS form from M. tuberculosis (29% identity in 35 amino acids). No such similarity was found to ArgO from C. jejuni. Since only the GCN5-related N-acetyltransferase (GNAT) domain was found to be conserved, and GNAT-domains can be found in N-acetyltransferases belonging to many different functional classes , it is apparent that Cg3035 represents a novel NAGS class.
Additional support for these two groups of orthologues can be derived from an analysis of the genomic context: in Corynebacterineae (including Corynebacterium spp., Mycobacterium spp., Nocardia spp., Rhodococcus ssp. and Gordonia ssp.), possible cg3035 orthologues are strongly associated with def2, encoding peptide deformylase, and xthA, encoding exodeoxyribonuclease III (Figure 5b). In contrast, the possible orthologue is often located adjacent to a gene encoding a ferredoxin in the second group. Therefore, only the sequences of the most likely orthologues, the 87 from Corynebacterineae, were realigned using COBALT and the location of the putative N-acyltransferase domain (based on a Pfam-A hit) was marked (Additional file 8).
Metabolite profiling analyses provide new insight into arginine biosynthesis
In the experiments described here, a systematic approach was performed using defined deletion mutants of C. glutamicum that were expected to accumulate intracellular metabolites. No stable isotope labelled internal standards for correction of ion suppression effects were used in these experiments, therefore, only a qualitative analysis of changes in metabolite pools could be performed. Six out of seven intermediates of arginine biosynthesis were found with the applied HPLC-ESI-qTOF method and the results provide new insights concerning metabolism within the arginine pathway. Interestingly, two metabolites accumulated in different mutants – N-acetylornithine was found in the two mutants ΔargRJ and ΔargRF, and citrulline accumulated in ΔargRG and ΔargRH mutants. In both cases, there was not only an accumulation in the mutant which was defective in the subsequent metabolic reaction, however, also in the strain with an inability to perform the second next reaction. This could indicate a backlog from the accumulated metabolite to its precursor.
N-acetylornithine was accumulated in ∆argRJ, which confirmed its anticipated function as ornithine acetyl transferase (OAT). The measurements of intracellular N-acetylglutamate confirmed this role by demonstrating a strongly reduced pool in the ∆argRJ mutant. For organisms having such a cyclic arginine pathway, this decrease illustrates a preference for transacetylation by ArgJ instead of using the less economic ArgA activity to produce N-acetylglutamate .
Since no transacetylation should occur in mutants upstream of ArgJ the behavior of ∆argRD mutant is consistent with a low intracellular N-acetylglutamate pool. It is puzzling, however, that in the ∆argRC mutant the N-acetylglutamate pool is similar to the ∆argRB mutant and the wildtype. In ∆argRB the accumulation of N-acetylglutamate can be explained by the interruption of biosynthesis. The unexpected high N-acetylglutamate pool in ∆argRC can either be interpreted by an equilibrium of the reaction catalysed by ArgB on the side of N-acetylglutamate or by a possible instability of the phosphorylated N-acetylglutamate and its breakdown to N-acetylglutamate. In the wildtype, the feedback inhibition of ArgB is the possible cause for accumulation of N-acetylglutamate.
In vivo and in vitro experiments confirm the ability of Cg3035 to acetylate l-glutamate
In this study, the function of Cg3035 to use acetyl-CoA for acetylation of glutamate was demonstrated in vivo and in vitro. Besides complementation of the auxotrophic E. coli ∆argA mutant, overexpression of cg3035 led to a higher amount of intracellular N-acetylglutamate, whereas deletion of this gene resulted in a reduction of the intracellular N-acetylglutamate pool. From in vitro enzyme assays using crude extracts it was shown that NAGS enzyme activity also correlated well with the genotype regarding cg3035. l-glutamate most probably is the preferred amino acid substrate for Cg3035. Interestingly, the S-NAGS variant in M. tuberculosis has a higher activity with l-glutamine . Indeed, N-acetylglutamine was found in all C. glutamicum strains tested, but in levels unaffected by the presence or absence of cg3035. Since no other N-acetylated amino acids were found in our metabolome analyses of C. glutamicum, this indicates that an involvement of Cg3035 in N-acetylglutamine synthesis is unlikely. On the other hand, the correspondence in the pools of N-acetylglutamate to those of the amino acids l-citrulline and l-arginine further strengthens the functional assignment of Cg3035 as integral part of arginine biosynthesis.
Cg3035 – A novel form of N-acetylglutamate synthase
The protein encoded by cg3035 can be compared to known NAGS enzyme classes. Four different kinds of NAGS enzyme families were described until now , however, Cg3035 fits into none of them. Different from classical known N-acetylglutamate synthases found, for example in E. coli, Cg3035 has only a single protein domain. With a length of 335 amino acids, it is shorter than the classical ArgA, although it is larger than the 150–180 amino acids long S-NAGS found, for example, in M. tuberculosis.
Homologues of the Cg3035 protein were found in other Corynebacteria as well as in diverse members of the suborder Corynebacterineae, such as in Rhodococcus spp., Nocardia spp., or Mycobacterium spp. Analysis of the genomic context revealed a conserved arrangement of three genes encoding peptide deformylase, N-acetylglutamate synthase, and exodeoxyribonuclease III among the fully sequenced genomes of this bacterial suborder. Although no functional relationship of these genes is apparent, the conserved genomic context strengthens the view that Cg3035 and its closely similar sequences in the other species of the Corynebacterineae represent true orthologues .
It is unclear what the evolutionary driving forces were for the formation of the different NAGS protein families. The dissimilarity of NAGS proteins was noted before and attributed to an independent evolution or a more rapid evolution leading to much higher divergence than the sequences of other arginine biosynthesis proteins .
Since the growth behaviour experiment on minimal medium revealed a bradytrophy of ∆cg3035 compared to the wildtype, this indicates that there is at least one other enzyme which is able to perform acetylation of glutamate in C. glutamicum ATCC 13032. Candidates for this are proteins with acetyltransferase domains. Besides Cg1722, eight other proteins with acetyltransferase domains are found in C. glutamicum, however, these have yet to be characterised.
It could be, however, that Cg3035 is not involved exclusively in arginine biosynthesis. This is not only indicated by the conserved arrangement of cg3035 with genes involved in peptide or RNA processing. The lack of transcriptional repression of cg3035 by ArgR and feedback inhibition of Cg3035 by one of the products of arginine biosynthesis, arginine or ornithine also suggests such a role. The initial transacetylation step is a common target to control arginine metabolism, indeed, all previously known microbial NAGS enzymes are feedback-inhibited by arginine. It is well possible that N-acetylglutamate is a non-exclusive precursor of arginine biosynthesis, however, is also involved in other biosynthesis pathways. Although it is not known what these biosynthetic pathways produce, the occurrence of N-acetylglutamine  is an indication for hitherto unknown pathways in Corynebacteria in which N-acetylglutamate could play a role. Consequently, in C. glutamicum, ArgB would then be the first enzyme of the arginine specific pathway and is feedback-inhibited by l-arginine .
In this study, we investigated the metabolites of arginine biosynthesis in targeted biosynthetic mutants of C. glutamicum. Through these investigations, we have found evidence for a missing enzyme which performs the first step of this process, the acetylation of glutamate catalysed by an N-acetylglutamate synthase.
By complementation of an auxotrophic E. coli ∆argA mutant with genomic DNA of C. glutamicum, the gene cg3035 was implicated as the enzyme responsible for this acetylation. A deletion of this gene led to a partial arginine auxotrophy and further experiments on genetic, enzymatic, and metabolomic levels demonstrated the ability of its encoded protein to act as NAGS, using acetyl-CoA for acetylation of glutamate. These findings added significantly to the knowledge on arginine metabolism in C. glutamicum. The NAGS enzyme Cg3035 establishes a novel class of N-acetylglutamate synthases with orthologues found exclusively in members of the suborder Corynebacterineae. Therefore, we propose to name this novel class of NAGS containing Cg3035 and its apparent orthologues C-NAGS (Corynebacterineae-type NAGS). This is simply a proposal, and it would be interesting to analyse in future studies if these orthologous candidates demonstrate functional catalysis of the same reaction.
Bacterial strains, growth conditions, plasmids, and oligonucleotides
Bacterial strains and plasmids
E. coli JM109
F´ traD36, proA + B + , lacI q Δ(lacZ,)M15/ Δ(lac-proAB), glnV44,e14 - , gyrA96, recA1, relA1, endA1, thi, hsdR17
E. coli JM109 ∆argA
JM109 with deleted argA gene
C. glutamicum ATCC 13032
Wild type (WT), Nxr
American type culture collection
C. glutamicum ATCC 13032 with deleted argR and argC genes
C. glutamicum ATCC 13032 with deleted argR and argJ genes
C. glutamicum ATCC 13032 with deleted argR and argB genes
C. glutamicum ATCC 13032 with deleted argR and argD genes
C. glutamicum ATCC 13032 with deleted argR and argF genes
C. glutamicum ATCC 13032 with deleted argR and argG genes
C. glutamicum ATCC 13032 with deleted argR and argH genes
C. glutamicum ATCC 13032 with deleted cg3035 gene
sacB, lacZα, Kmr , mcs mobilizable vector, allows for selection of double crossover in C. glutamicum
E. coli-C. glutamicum shuttle expression vector, Ptac, Kmr
modified pZ8-1 where the multiple cloning site was exchanged by a sole Bam HI-site and a consensus RBS was included
pZ8-1 containing the argA structural gene from E. coli
pZ8-1 containing the cg3035 structural gene from C. glutamicum ATCC 13032
pZ8-1 containing the argJ structural gene from C. glutamicum ATCC 13032
E. coli strains carrying plasmids were routinely grown on solid Antibiotic Medium No. 3 (PA) (Oxoid, Wesel, Germany) at 37°C. Tests for arginine auxotrophy were performed using M9 minimal medium plates . When needed, antibiotics were added at the following concentrations: 50 μg mL-1 kanamycin for E. coli and 25 μg mL-1 kanamycin and 50 μg mL-1 nalidixic acid for C. glutamicum. Bacterial growth was monitored by measuring the optical density at 600 nm (OD600).
DNA isolation, manipulation, and analysis
Chromosomal DNA of C. glutamicum and E. coli MG1655 was isolated as described previously . Isolation of plasmid DNA from E. coli cells was done by using a GeneJET Plasmid Miniprep Kit (Fermentas, St. Leon-Rot, Germany). PCR amplification of DNA was carried out with Phusion polymerase (Finnzymes, Vantaa, Finland) in an Eppendorf Mastercycler pro S. All PCR setups were done according to the manufacturers´ protocols. Modification of DNA, analysis by agarose gel electrophoresis and ligation were performed using standard procedures . All oligonucleotides used in this study (Additional file 9) were obtained from Metabion (Martinsried, Germany). PCR products were purified with a NucleoSpin Gel and PCR Clean-up Kit (Macherey-Nagel, Düren, Germany). Transformation of E. coli with plasmid DNA was performed using the rubidium chloride method , C. glutamicum cells were transformed by electroporation .
Construction of defined chromosomal deletions
Plasmids for defined chromosomal deletions in C. glutamicum ATCC 13032 from start to stop codon were constructed using the geneSOEing method described by Horton et al.. In each deletion, the complete coding regions were removed exactly. One exception was the deletion of argB, since it contains the ribosome-binding site (RBS) for the argD coding sequence located downstream. In this case, the deletion of argB was carried out in a way that its RBS was fused to the argD coding region in a proper distance. The resulting fusion products were digested with restriction enzymes corresponding to the cleavage sites introduced via PCR (Additional file 9) and ligated into an appropriately digested pK18mobsacB. The final non-replicable plasmids were transformed into C. glutamicum ATCC 13032 and integration into the chromosome by single-crossover was selected on CASO (Carl Roth, Karlsruhe, Germany) plates supplemented with 25 μg mL-1 kanamycin. A second recombination to enable plasmid excision was performed by spreading the transformants on CASO plates containing 10% (w/v) sucrose. Colonies from these plates were tested for the desired kanamycin-sensitive and sucrose-resistant phenotype by parallel picking. PCR experiments were used to verify deletions in the C. glutamicum chromosome.
For construction of E. coli JM109 ∆argA the Quick & Easy E. coli Gene Deletion Kit (Gene Bridges, Heidelberg, Germany) was used. Red/ET cloning and removal of the selection marker was performed according to the manufacturer’s instructions.
Construction of expression vectors
To generate overexpression constructs of genes coding for a putative N-acetylglutamate synthase, genes of interest were amplified via PCR using C. glutamicum ATCC 13032 or E. coli MG1655 genomic DNA, respectively. The PCR primers used are listed in Additional file 9. The resulting PCR products were cleaved using restriction sites added by the PCR primers and ligated into plasmid pZ8-1, digested with the corresponding enzymes. After transformation of E. coli JM109, the obtained plasmids were isolated and their inserts sequenced. The final plasmids were then transformed into E. coli JM109 ∆argA and C. glutamicum strains.
To ensure translation of inserted ORFs in E. coli, the multiple cloning site of the shuttle expression vector pZ8-1 was exchanged by a sole Bam HI-site. Additionally, a consensus ribosomal binding site (RBS) of highly expressed genes (identical to the complement of mRNA-binding site of the 16S rRNA ) was cloned upstream this restriction site. The resulting vector was named pZ8-2.
Generation of a genomic library from C. glutamicum ATCC 13032 and complementation of E. coli JM109 ∆argA
Isolation of genomic DNA was performed as described elsewhere . Five micrograms of DNA were partially fragmented by the restriction enzyme Bsp 143I (Sau 3AI) for 4 minutes. Since this step generated sticky ends complementary to the Bam HI-site, cloning in a vector was enabled. The size distribution of genomic DNA fragments was analysed on a DNA High Sensitivity chip by an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, Canada). The total DNA concentration was 41.75 ng μL-1, comprising fragments in the range of 700–9000 bp with an average DNA fragment size of 4.2 kb. Genomic DNA fragments were cloned into the constitutively expressing pZ8-2 vector harboring a Ptac-promoter. Partially digested genome and linear pZ8-2 vector were ligated and transformed into E. coli JM109 ΔargA mutant. Before plating on M9 minimal medium plates with kanamycin, the transformed cells were washed with 1x TE buffer to remove remaining components of the regeneration medium, for example amino acids. M9 minimal medium plates were incubated for 48 h at 37°C.
Cell harvesting, metabolite extraction, and sample preparation
Cell harvesting and metabolite extraction were performed as previously [48, 49]. Two milliliters of bacterial culture were transferred into a 2 mL reaction tube with screw cap and centrifuged at 20,000 × g for 15 s. The supernatant was discarded and the cell pellet was immediately frozen in liquid nitrogen. Frozen cell pellets were freeze-dried within 16 h, using a Christ RVC 2-18 rotational-vacuum-concentrator in combination with a Christ CT 02-50 cooling trap (Martin Christ, Osterode, Germany) and a RZ 2.5 rotary vane pump (Vacuubrand, Wertheim, Germany). A total of 950 mg of silica beads (0.5 mm dia.) and 1 mL of aqueous methanol 80% (v/v) containing 20 μM 2-aminobenzimidazole were added, cells were then disrupted by shaking 3 times in a Precellys 24 (PEQLAB Biotechnologie, Erlangen, Germany) mill at 6,000 rpm with 1 min cycles and 5 s breaks. Cell debris was separated by centrifugation at 20,000 × g at RT for 20 min. Seven hundred microliters of the hydrophilic extracts were transferred into 1.5 mL glass vials and evaporated to complete dryness under a nitrogen stream using a Reacti-Therm III heating/stirring module equipped with a Reacti-Vap III nitrogen evaporator (Pierce, Rockford, IL, USA).
Sample preparation for qualitative LC-MS analysis
Samples were dissolved in 200 μL of water and mixed by vortexing for 10 s. In order to remove remaining particles, samples were transferred into 1.5 mL reaction tubes and centrifuged at 20,000 rpm at 4°C for 20 min. Supernatants were transferred into new 1.5 mL reaction tubes and stored at -80°C. Prior to analysis, a 10 μL aliquot of each sample was transferred into a 1.5 mL glass vial with inlet (5 mm dia.). Subsequently, 0.1 μL formic acid and 90 μL acetonitrile were added. Samples were mixed by vortexing for 5 s and placed into the autosampler.
Sample preparation for quantitative LC-MS analysis
Samples were dissolved in 50 μL of water and mixed by vortexing for 10 s. Samples were transferred into 1.5 mL reaction tubes and centrifuged at 20,000 rpm at 4°C for 20 min to remove remaining particles. Supernatants were transferred into new 1.5 mL reaction tubes and stored at -80°C. Prior to analysis, a 15 μL aliquot of each sample was transferred into a 1.5 mL glass vial with inlet (5 mm dia.) and 5 μL of 13C-labelled internal standard was added. Samples were mixed by vortexing for 5 s and placed into the autosampler.
LC-MS data were obtained using a LaChromUltra (Hitachi Europe, UK) HPLC system coupled to a microTOF-Q hybrid quadrupole/time-of-flight mass spectrometer (Bruker Daltonics, Bremen, Germany), equipped with an electrospray ionisation (ESI) source. Separation of metabolites was performed on a Cogent diamond hydride column (MicroSolv Technologies; 150 × 2.1 mm; 3 μm particles) operated in aqueous normal phase mode. Eluent A: 50% acetonitrile (v/v), 50% water (v/v) + 0.1% (v/v) formic acid and B: 90% acetonitrile (v/v), 10% water (v/v) + 0.1% (v/v) formic acid were prepared freshly and stored in PTFE bottles. Flow rate was set to 400 μL min-1 and gradient elution was performed as follows: t = 0 min, 100% B; t = 6 min 0% B; t = 7 min, 0% B; t = 8.5 min 100% B; t = 13 min 100% B. MS detection was performed with ESI source operated in positive ionisation mode (Additional file 11). Nitrogen was used as sheath, dry, and collision gas. Sodium formate solution (0.1 M) in 50% (v/v) isopropanol was used for external mass calibration and was injected into the ESI source at the beginning of each analysis, using a switch valve and a segmented acquisition method. For targeted detection of N-acetylglutamate, multiple reaction monitoring (MRM) was applied. An additional segment was introduced (Additional file 12), during which the pseudomolecular ion was isolated and fragmented to generate characteristic product ions.
Processing of LC-MS(/MS) Data
Raw data were analysed using the Compass software environment (Bruker Daltonics, Bremen, Germany). Automatic internal mass calibration using an HPC quadratic algorithm and identification of compounds was achieved using Compass DataAnalysis (version 4.0 SP1). The following steps were performed using Compass QuantAnalysis (version 2.0 SP1). This included targeted generation of base peak chromatograms (BPCs) for expected m/z-values of [M + H]+ ions (Additional file 13), peak detection, peak integration, and normalisation to the peak areas of the internal standard. Normalisation of resulting peak areas to cell dry weight (CDW) of samples, calculation of mean values, calculation of standard deviation over biological replicates, and relative quantification were performed in a spreadsheet. To test significance of differences in normalised peak areas between different strains, a two-tailed Student’s T-test was applied.
Theoretical fragmentation patterns and mechanisms of selected metabolites were generated on the basis of chemical structure files using Mass Frontier 4.0 Spectral Interpretation Software (HighChem, Bratislava, Slovakia).
Preparation of crude protein extracts of bacterial cultures
C. glutamicum protein extracts were prepared from cells grown to mid-exponential growth phase in liquid CGXII medium. Twenty-five milliliters of bacterial culture was harvested by 10 min of centrifugation at 4°C and 4,500 × g. Cell pellets were washed in 25 mL of 100 mM Tris-HCl (pH 7.5) which was supplemented with 20 μM PMSF. After removal of the supernatant, cells were resuspended in 5 mL of 100 mM Tris-HCl (pH 7.5) containing 20 μM PMSF. Cell suspension was split to four 2 mL reaction tubes containing silica beads. Cell disruption using the Precellys 24 bead mill was carried out at a speed ratio of 6.5 for three time intervals of 30 s. Cell debris was removed by 20 min of centrifugation at 4°C and 14,000 rpm. Protein concentrations of the crude extracts were determined by using Roti-Nanoquant (Roth, Karlsruhe, Germany), a modified Bradford assay, according to instructions of the manufacturer.
Measurement of NAGS enzyme activity
Reaction was maintained at 25°C and continuously monitored spectrophotometrically in a total volume of 500 μL. Assay mixtures contained 500 mM l-glutamate, 0.2 mM acetyl-CoA and 0.2 mM DTNB. All these substances were dissolved in 100 mM Tris-HCl (pH 7.5). Reactions were initiated by addition of 10 μL of protein extract. One unit of enzymatic activity is the amount of enzyme catalysing the formation of 1 μmol of N-acetylglutamate min-1 and specific NAGS activity was calculated as the activity of enzyme per milligram of total protein.
Acknowledgements & funding
This work was funded by the German Federal Ministry of Education and Research, “SysEnCor” project, grant 0315827C. It was supported by the CLIB Graduate Cluster. We acknowledge support of the publication fee by Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University. We thank Iris Wiegräbe for construction of the plasmid pK18::∆argR and the strain C. glutamicum ∆argR. We also thank Kyle J. Lauersen for critical manuscript and English language editing.
- Caldovic L, Tuchman M: N-Acetylglutamate and its changing role through evolution. Biochem J. 2003, 372: 279-290. 10.1042/BJ20030002.PubMed CentralView ArticlePubMedGoogle Scholar
- Glansdorff N, Ying X: Microbial arginine biosynthesis: pathway, regulation and industrial production. Amino acid biosynthesis: pathways, regulation and metabolic engineering. Edited by: Wendisch VF. 2007, Wiesbaden: Springer, 219-257. [Steinbüchel A (Series editor): Microbiology Monographs, vol 5.]View ArticleGoogle Scholar
- Maas WK, Novelli GD, Lipmann F: Acetylation of glutamic acid by extracts of Escherichia coli. Proc Natl Acad Sci. 1953, 39: 1004-1008. 10.1073/pnas.39.10.1004.PubMed CentralView ArticlePubMedGoogle Scholar
- Ramón-Maiques S, Marina A, Gil-Ortiz F, Fita I, Rubio V: Structure of acetylglutamate kinase, a key enzyme for arginine biosynthesis and a prototype for the amino acid kinase enzyme family, during catalysis. Structure. 2002, 10: 329-342. 10.1016/S0969-2126(02)00721-9.View ArticlePubMedGoogle Scholar
- Maas WK: Studies on repression of arginine biosynthesis in Escherichia coli. Cold Spr Harb Symp Quant Biol. 1961, 26: 183-191. 10.1101/SQB.1961.026.01.023.View ArticleGoogle Scholar
- Powers-Lee SG: N-Acetylglutamate synthase. Meth Enzymol. 1985, 113: 27-35.View ArticlePubMedGoogle Scholar
- Cunin R, Glansdorff N, Piérard A, Stalon V: Biosynthesis and metabolism of arginine in bacteria. Microbiol Rev. 1986, 50: 314-352.PubMed CentralPubMedGoogle Scholar
- Sakanyan V, Petrosyan P, Lecocq M, Boyen A, Legrain C, Demarez M, Hallet J, Glansdorff N: Genes and enzymes of the acetyl cycle of arginine biosynthesis in Corynebacterium glutamicum: enzyme evolution in the early steps of the arginine pathway. Microbiology. 1996, 142: 99-108. 10.1099/13500872-142-1-99.View ArticlePubMedGoogle Scholar
- Marc F, Weigel P, Legrain C, Almeras Y, Santrot M, Glansdorff N, Sakanyan V: Characterization and kinetic mechanism of mono- and bifunctional ornithine acetyltransferases from thermophilic microorganisms. Eur J Biochem. 2000, 267: 5217-5226. 10.1046/j.1432-1327.2000.01593.x.View ArticlePubMedGoogle Scholar
- Udaka S: Pathway-specific pattern of control of arginine biosynthesis in bacteria. J Bacteriol. 1966, 91: 617-621.PubMed CentralPubMedGoogle Scholar
- Martin PR, Mulks MH: Sequence analysis and complementation studies of the argJ gene encoding ornithine acetyltransferase from Neisseria gonorrhoeae. J Bacteriol. 1992, 174: 2694-2701.PubMed CentralPubMedGoogle Scholar
- Sakanyan V, Kochikyan A, Mett I, Legrain C, Charlier D, PieRard A, Glansdorff N: A re-examination of the pathway for ornithine biosynthesis in a thermophilic and two mesophilic Bacillus species. J Gen Microbiol. 1992, 138: 125-130. 10.1099/00221287-138-1-125.View ArticleGoogle Scholar
- Errey JC, Blanchard JS: Functional characterization of a novel ArgA from Mycobacterium tuberculosis. J Bacteriol. 2005, 187: 3039-3044. 10.1128/JB.187.9.3039-3044.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Xu Y, Glansdorff N, Labedan B: Bioinformatic analysis of an unusual gene-enzyme relationship in the arginine biosynthetic pathway among marine gamma proteobacteria: implications concerning the formation of N-acetylated intermediates in prokaryotes. BMC Genomics. 2006, 7: 4-10.1186/1471-2164-7-4.PubMed CentralView ArticlePubMedGoogle Scholar
- Xu Y, Liang Z, Legrain C, Rüger HJ, Glansdorff N: Evolution of arginine biosynthesis in the bacterial domain: novel gene-enzyme relationships from psychrophilic Moritella strains (Vibrionaceae) and evolutionary significance of N-α-acetyl ornithinase. J Bacteriol. 2000, 182: 1609-1615. 10.1128/JB.182.6.1609-1615.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Udaka S, Kinoshita S: Studies on L-ornithine fermentation. I. The biosynthetic pathway of L-ornithine in Micrococcus glutamicum. J Gen Appl Microbiol. 1958, 4: 272-282. 10.2323/jgam.4.272.View ArticleGoogle Scholar
- Hwang G, Cho J: Identification of a suppressor gene for the arginine-auxotrophic argJ mutation in Corynebacterium glutamicum. J Ind Microbiol Biotechnol. 2010, 37: 1131-1136. 10.1007/s10295-010-0760-3.View ArticlePubMedGoogle Scholar
- Kind S, Jeong WK, Schroder H, Zelder O, Wittmann C: Identification and elimination of the competing N-acetyldiaminopentane pathway for improved production of diaminopentane by Corynebacterium glutamicum. Appl Environ Microb. 2010, 76: 5175-5180. 10.1128/AEM.00834-10.View ArticleGoogle Scholar
- Ikeda M, Mitsuhashi S, Tanaka K, Hayashi M: Reengineering of a Corynebacterium glutamicum L-Arginine and L-Citrulline producer. Appl Environ Microb. 2009, 75: 1635-1641. 10.1128/AEM.02027-08.View ArticleGoogle Scholar
- Barsch A, Patschkowski T, Niehaus K: Comprehensive metabolite profiling of Sinorhizobium meliloti using gas chromatography–mass spectrometry. Funct Integr Genomics. 2004, 4: 219-230.View ArticlePubMedGoogle Scholar
- Fuhrer T, Heer D, Begemann B, Zamboni N: High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. Anal Chem. 2011, 83: 7074-7080. 10.1021/ac201267k.View ArticlePubMedGoogle Scholar
- Kalinowski J, Bathe B, Bartels D, Bischoff N, Bott M, Burkovski A, Dusch N, Eggeling L, Eikmanns BJ, Gaigalat L, Goesmann A, Hartmann M, Huthmacher K, Krämer R, Linke B, McHardy AC, Meyer F, Möckel B, Pfefferle W, Pühler A, Rey DA, Rückert C, Rupp O, Sahm H, Wendisch VF, Wiegräbe I, Tauch A: The complete Corynebacterium glutamicum ATCC 13032 genome sequence and its impact on the production of L-aspartate-derived amino acids and vitamins. J Biotechnol. 2003, 104: 5-25. 10.1016/S0168-1656(03)00154-8.View ArticlePubMedGoogle Scholar
- Pfeifer-Sancar K, Mentz A, Rückert C, Kalinowski J: Comprehensive analysis of the Corynebacterium glutamicum transcriptome using an improved RNAseq technique. submitted for publicationGoogle Scholar
- Marchler-Bauer A, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Lu S, Marchler GH, Mullokandov M, Song JS, Tasneem A, Thanki N, Yamashita RA, Zhang D, Zhang N, Bryant SH: CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res. 2009, 37: D205-D210. 10.1093/nar/gkn845.PubMed CentralView ArticlePubMedGoogle Scholar
- Amador E, Castro JM, Correia A, Martin JF: Structure and organization of the rrnD operon of 'Brevibacterium lactofermentum': analysis of the 16S rRNA gene. Microbiology. 1999, 145: 915-924. 10.1099/13500872-145-4-915.View ArticlePubMedGoogle Scholar
- Liebl W: Corynebacterium Taxonomy. Handbook of Corynebacterium glutamicum. Edited by: Eggeling L, Bott M. 2005, Boca Raton, FL: CRC Press, 9-34.View ArticleGoogle Scholar
- Vyas S, Maas W: Feedback inhibition of acetylglutamate synthetase by arginine in Escherichia coli. Arch Biochem Biophys. 1963, 100: 542-546. 10.1016/0003-9861(63)90124-3.View ArticlePubMedGoogle Scholar
- Haas D, Leisinger T: In vitro assay and some properties of N-acetylglutamate synthetase from Escherichia coli. Pathol Microbiol. 1974, 40: 140-141.Google Scholar
- Abdelal AT, Nainan OV: Regulation of N-acetylglutamate synthesis in Salmonella typhimurium. J Bacteriol. 1979, 137: 1040-1042.PubMed CentralPubMedGoogle Scholar
- Haas D, Kurer V, Leisinger T: N-acetylglutamate synthetase of Pseudomonas aeruginosa. An assay in vitro and feedback inhibition by arginine. Eur J Biochem. 1972, 31: 290-295. 10.1111/j.1432-1033.1972.tb02531.x.View ArticlePubMedGoogle Scholar
- Wipe B, Leisinger T: Regulation of activity and synthesis of N-acetylglutamate synthase from Saccharomyces cerevisiae. J Bacteriol. 1979, 140: 874-880.PubMed CentralPubMedGoogle Scholar
- Hani EK, Ng D, Chan VL: Arginine biosynthesis in Campylobacter jejuni TGH9011: determination of the argCOBD cluster. Can J Microbiol. 1999, 45: 959-969.View ArticlePubMedGoogle Scholar
- Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25: 3389-3402. 10.1093/nar/25.17.3389.PubMed CentralView ArticlePubMedGoogle Scholar
- Vetting MW, de Carvalho LP S, Yu M, Hegde SS, Magnet S, Roderick SL, Blanchard JS: Structure and functions of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys. 2005, 433: 212-226. 10.1016/j.abb.2004.09.003.View ArticlePubMedGoogle Scholar
- Papadopoulos JS, Agarwala R: COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics. 2007, 23: 1073-1079. 10.1093/bioinformatics/btm076.View ArticlePubMedGoogle Scholar
- Whitman WB, Goodfellow M, Kämpfer P: Bergey's Manual of Systematic Bacteriology: Volume 5: The Actinobacteria. 2012, Dordrecht: Springer, 2Google Scholar
- Martinez-Guerrero CE, Ciria R, Abreu-Goodger C, Moreno-Hagelsieb G, Merino E: GeConT 2: gene context analysis for orthologous proteins, conserved domains and metabolic pathways. Nucleic Acids Res. 2008, 36: W176-W180. 10.1093/nar/gkn330.PubMed CentralView ArticlePubMedGoogle Scholar
- Haran N, Kahana ZE, Lapidot A: In vivo 15N NMR studies of regulation of nitrogen assimilation and amino acid production by Brevibacterium lactofermentum. J Biol Chem. 1983, 258: 12929-12933.PubMedGoogle Scholar
- Keilhauer C, Eggeling L, Sahm H: Isoleucine synthesis in Corynebacterium glutamicum: molecular analysis of the ilvB-ilvN-ilvC operon. J Bacteriol. 1993, 175: 5595-5603.PubMed CentralPubMedGoogle Scholar
- Schneider J, Niermann K, Wendisch VF: Production of the amino acids l-glutamate, l-lysine, l-ornithine and l-arginine from arabinose by recombinant Corynebacterium glutamicum. J Biotechnol. 2011, 154: 191-198. 10.1016/j.jbiotec.2010.07.009.View ArticlePubMedGoogle Scholar
- Schäfer A, Tauch A, Jäger W, Kalinowski J, Thierbach G, Pühler A: Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. Gene. 1994, 145: 69-73. 10.1016/0378-1119(94)90324-7.View ArticlePubMedGoogle Scholar
- Dusch N, Pühler A, Kalinowski J: Expression of the Corynebacterium glutamicum panD gene encoding L-aspartate-alpha-decarboxylase leads to pantothenate overproduction in Escherichia coli. Appl Environ Microbiol. 1999, 65: 1530-1539.PubMed CentralPubMedGoogle Scholar
- Sambrook J, Russell DW: Molecular cloning: A laboratory manual. 2001, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 3Google Scholar
- Tauch A, Kassing F, Kalinowski J, Pühler A: The Corynebacterium xerosis: composite transposon Tn5432 consists of two identical insertion sequences, designated IS1249, flanking the erythromycin resistance gene ermCX. Plasmid. 1995, 34: 119-131. 10.1006/plas.1995.9995.View ArticlePubMedGoogle Scholar
- Hanahan D: Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983, 166: 557-580. 10.1016/S0022-2836(83)80284-8.View ArticlePubMedGoogle Scholar
- Tauch A, Kirchner O, Löffler B, Götker S, Pühler A, Kalinowski J: Efficient electrotransformation of Corynebacterium diphtheriae with a mini-replicon derived from the Corynebacterium glutamicum plasmid pGA1. Curr Microbiol. 2002, 45: 362-367. 10.1007/s00284-002-3728-3.View ArticlePubMedGoogle Scholar
- Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR: Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989, 77: 61-68. 10.1016/0378-1119(89)90359-4.View ArticlePubMedGoogle Scholar
- Plassmeier J, Barsch A, Persicke M, Niehaus K, Kalinowski J: Investigation of central carbon metabolism and the 2-methylcitrate cycle in Corynebacterium glutamicum by metabolic profiling using gas chromatography–mass spectrometry. J Biotechnol. 2007, 130: 354-363. 10.1016/j.jbiotec.2007.04.026.View ArticlePubMedGoogle Scholar
- Persicke M, Plassmeier J, Neuweger H, Rückert C, Pühler A, Kalinowski J: Size exclusion chromatography - An improved method to harvest Corynebacterium glutamicum cells for the analysis of cytosolic metabolites. J Biotechnol. 2011, 154: 171-178. 10.1016/j.jbiotec.2010.08.016.View ArticlePubMedGoogle Scholar
- Rückert C, Milse J, Albersmeier A, Koch DJ, Pühler A, Kalinowski J: The dual transcriptional regulator CysR in Corynebacterium glutamicum ATCC 13032 controls a subset of genes of the McbR regulon in response to the availability of sulphide acceptor molecules. BMC Genomics. 2008, 9: 483-10.1186/1471-2164-9-483.PubMed CentralView ArticlePubMedGoogle Scholar
- Dondrup M, Albaum SP, Griebel T, Henckel K, Jünemann S, Kahlke T, Kleindt CK, Küster H, Linke B, Mertens D, Mittard-Runte V, Neuweger H, Runte KJ, Tauch A, Tille F, Pühler A, Goesmann A: EMMA 2 – a MAGE-compliant system for the collaborative analysis and integration of microarray data. BMC Bioinformatics. 2009, 10: 50-10.1186/1471-2105-10-50.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.